Laparoscopic Gynecological Procedures Global Market Report 2024

The laparoscopic gynecological procedures market size has grown strongly in recent years. It will grow from $23.74 billion in 2023 to $25.51 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be attributed to several factors, including the high prevalence of ovarian cysts, changes in the regulatory landscape, increased healthcare expenditure, expansion of healthcare infrastructure, and the rise in the prevalence of colorectal cancer.

The laparoscopic gynecological procedures market size is expected to see strong growth in the next few years. It will grow to $34.31 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The projected growth in the forecast period is expected to be driven by factors such as the increasing incidence of gynecological disorders, a growing aging population, expansion of indications for laparoscopic procedures, and rising acceptance of minimally invasive surgical techniques. Significant trends anticipated for this period encompass technological advancements, innovations in endoscopic technology, advancements in minimally invasive surgical techniques, collaboration among gynecologists, and the integration of artificial intelligence into gynecological procedures.

The increasing prevalence of gynecological cancer is poised to fuel the expansion of the laparoscopic gynecological procedures market in the foreseeable future. Gynecologic cancer encompasses cancers originating in a woman's reproductive organs, including the ovary, uterus, cervix, vagina, and vulva. Several factors contribute to the incidence of gynecological cancers, such as an aging population, longer life expectancy, elevated rates of obesity, smoking, and physical inactivity. Laparoscopic gynecological procedures play a crucial role in mitigating the prevalence of gynecological cancer by treating and managing the disease, averting recurrence, and enhancing patient outcomes through various therapeutic interventions. For example, according to the World Ovarian Cancer Coalition, ovarian cancer afflicted 313,959 women globally in 2020, with projections indicating a 42% increase to 445,721 cases by 2040. Similarly, deaths from ovarian cancer are anticipated to rise by 51% from 207,252 to 313,617 during the same period. Hence, the significant prevalence of gynecological cancer is a driving force behind the growth of the laparoscopic gynecological procedures market.

Leading companies in the laparoscopic gynecological procedures market are directing their efforts toward developing innovative technologies, such as state-of-the-art laparoscopic imaging systems, to enhance surgical precision, visualization, and patient outcomes. Advanced laparoscopic imaging systems comprise cutting-edge technologies and equipment utilized to visualize the surgical field during laparoscopic procedures with exceptional clarity, precision, and detail. For instance, in May 2023, B. Braun introduced its latest laparoscopic imaging system, the AESCULAP EinsteinVision 3 FI, designed for minimally invasive surgery procedures. This advanced system incorporates 3D fluorescence imaging (FI) technology, enabling real-time imaging through three different FI overlay modes. It caters to various minimally invasive surgery applications, including vessel or visceral perfusion assessment, visualization of bile duct anatomy, and (sentinel) lymph node mapping. The system, equipped with a camera processor featuring integrated documentation, a high-resolution monitor screen, and a stereo endoscope, ensures high visual quality, thereby enhancing surgical outcomes and efficiency.

In October 2021, Hologic Inc. acquired Bolder Surgical LLC for $160 million, aiming to expand its surgical portfolio with Bolder's advanced energy vessel sealing and dissection tools. This strategic acquisition bolsters Hologic's laparoscopic offerings, reaffirming its commitment to women's health by providing OB/GYN specialists with minimally invasive treatments and state-of-the-art vessel sealing technology. Bolder Surgical LLC specializes in manufacturing surgical instruments and devices tailored for gynecologic surgery.

Major companies operating in the laparoscopic gynecological procedures market are Johnson & Johnson, Bayer HealthCare, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific, B. Braun Melsungen, Zimmer Biomet, Intuitive Surgical, Smith & Nephew, Hologic Inc., CooperSurgical, W. L. Gore & Associates, Teleflex Incorporated, Karl Storz GmbH, Cook Medical, ConMed Corporation, KLS Martin Group, Applied Medical, Aesculap Inc., Richard Wolf GmbH, Lumenis Ltd., ERBE Elektromedizin GmbH, DYSIS Medical, EndoGastric Solutions.

North America was the largest region in the laparoscopic gynecological procedures market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laparoscopic gynecological procedures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the laparoscopic gynecological procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Laparoscopic gynecological procedures are minimally invasive surgical techniques performed in the field of gynecology using laparoscopic instruments and equipment. These procedures involve accessing the pelvic and abdominal cavities through small incisions instead of the traditional large incisions used in open surgery.

The main types of laparoscopic gynecological procedures are laparoscopic hysterectomy, laparoscopic myomectomy, laparoscopic colpopexy (sacrocolpopexy, sacrocervicopexy, and more), laparoscopic endometrial excision, laparoscopic adnexal (oophorectomy, salpingo-oophorectomy, and more), and laparoscopic diagnostic procedures (requiring chromopertubation). Several products are involved, such as surgical devices, gynecological imaging devices, and portable tools, by several end-users, including hospitals, clinics, and ambulatory surgery centers (ASCs).

The laparoscopic gynecological procedures market research report is one of a series of new reports that provides laparoscopic gynecological procedures market statistics, including laparoscopic gynecological procedures industry global market size, regional shares, competitors with a laparoscopic gynecological procedures market share, detailed laparoscopic gynecological procedures market segments, market trends and opportunities, and any further data you may need to thrive in the laparoscopic gynecological procedures industry. This laparoscopic gynecological procedures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The laparoscopic gynecological procedures market includes revenues earned by entities by providing services, such as the management of ovarian pathologies, fertility enhancement, ectopic pregnancy management, treatment of gynecological cancers, and pelvic floor reconstruction. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.